Medical News

RSS

China Health first quarter gross revenues increase 52% to $6.759 million

China Health Labs & Diagnostics Ltd. is pleased to announce the financial results for the first quarter ended March 31, 2011.

29 Jun 2011

Exciton enters distribution agreement with Marathon Medical

Exciton Technologies Inc. today announced the Company has signed a distribution agreement with Marathon Medical, adding them to the existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs on behalf of the U.S. General Services Administration (GSA), effective July 1st.

29 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Newly revised and expanded editions of CRA's and CRC's guides released

CenterWatch, a leading publisher in the clinical trials industry, announced today the release of newly revised and expanded editions of two of its top-selling training resources—The CRA's Guide to Monitoring Clinical Trials, 3rd Edition, and The CRC's Guide to Coordinating Clinical Trials, 2nd Edition.

29 Jun 2011

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears.

29 Jun 2011

Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing

Acetylon Pharmaceuticals, Inc. announced today that it has completed a $27 million Series B Preferred equity investment round of financing.

29 Jun 2011

Humans experience the Motion Aftereffect even if the motion is brief

Scientists have come up with new insight into the brain processes that cause the following optical illusion: Focus your eyes directly on the "X" in the center of the image in this short video (http://www.youtube.com/watch?v=BXnUckHbPqM&feature=player_embedded)

29 Jun 2011

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.

29 Jun 2011

First Edition: June 29, 2011

In today's news, two senators offer a new plan for Medicare cuts -- which includes increasing the eligibility age -- but top Democrats lined up against it.

29 Jun 2011

RxMD and GlycoRegImmune enter drug development collaboration

RxMD, Inc., a privately-held, global therapeutics development company, today announced a collaboration agreement with GlycoRegImmune Inc. (GRI) to develop new treatments for inflammatory, autoimmune, and neurodegenerative conditions based on GRI's novel natural killer (NK) T cell targeted technologies.

29 Jun 2011

South African circumcision program moving forward with support from Zulu king

NPR's Morning Edition on Monday examined how a circumcision program in South Africa's Kwa-Zulu Natal, run by the Society for Family Health at the Boom Street Community Health Clinic, "is gaining momentum" because of a decree issued last year by King Goodwill Zwelithini kaBhekuzulu about the importance of circumcision in helping to reduce the risk of HIV infection.

29 Jun 2011

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

29 Jun 2011

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.

29 Jun 2011

NPR examines maternal, child health in Mozambique

NPR's All Things Considered reports on efforts to improve maternal health in Mozambique. The piece, which is part of a summer series, looks at the challenges involved with getting pregnant women to hospitals and shortages of trained health worker (Block, 6/27).

29 Jun 2011

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

GenSpera, Inc. has entered into a cooperation agreement with the University of Copenhagen, in Copenhagen, Denmark, to collaborate on the "SPOTLight" (Sustainable Production of Thapsigargin using Light) project.

29 Jun 2011

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.

29 Jun 2011

South Sudan should use military as force for development

Calestous Juma, an author and professor at Harvard Kennedy School, writes in an East African opinion piece that as South Sudan prepares for independence on July 9, it "is the time" for the country "to chart a new path by defining a new role for its military" by "shift[ing] its military budget to development objectives."

29 Jun 2011

PEP intervention increases breast cancer awareness

Educating women about breast cancer increases their knowledge about the disease should they develop a symptom - and could help increase survival from breast cancer, new research today shows.

29 Jun 2011

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).

29 Jun 2011

Stop ignoring historical western advocacy of sex selection

Mara Hvistendahl, a correspondent with Science magazine and author of the recently published "Unnatural Selection: Choosing Boys over Girls, and the Consequences of a World Full of Men," writes in a Foreign Policy feature that "as American politicians argue over whether to cut Planned Parenthood's U.S. funding and the Christian right drives through bans on sex-selective abortion at the state level, the effects of three decades of sex selection elsewhere in the world are becoming alarmingly apparent.

29 Jun 2011

Medical News

China Health first quarter gross revenues increase 52% to $6.759 million

Exciton enters distribution agreement with Marathon Medical

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Newly revised and expanded editions of CRA's and CRC's guides released

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing

Humans experience the Motion Aftereffect even if the motion is brief

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

First Edition: June 29, 2011

RxMD and GlycoRegImmune enter drug development collaboration

South African circumcision program moving forward with support from Zulu king

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

NPR examines maternal, child health in Mozambique

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

South Sudan should use military as force for development

PEP intervention increases breast cancer awareness

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

Stop ignoring historical western advocacy of sex selection

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News